Stem Cell Therapy Earnings
U.S. Stem Cell, Inc. (OTCQB: USRM) Drops 13.47% After Reporting Full Year 2016 Earnings
Matt Rego - March 16, 2017
U.S. Stem Cell, Inc. (OTCQB: USRM) is a regenerative therapeutics company, using stem cells. Shares of the stem cell company is declining 13.47%, through...